Monitor for any subsequent conversion of this 13G to a 13D, which would signal activist intent. Kevin Tang has a history of taking positions in small-cap biotechs and pushing for strategic alternatives. The 6.0% stake is below the 10% threshold that typically triggers more aggressive engagement, but Tang's track record suggests potential for escalation.
Price Chart
Executive Summary
Tang Capital Management, LLC and affiliated entities (Kevin Tang) filed a Schedule 13G disclosing a 6.0% passive stake in Skye Bioscience, Inc. as of October 7, 2026. The filing indicates no intent to influence control, but the involvement of Kevin Tang—a known activist investor—warrants attention despite the passive designation.
Key Financial Metrics
Key Facts
- Tang Capital Management and affiliates beneficially own 263,560 shares of Skye Bioscience common stock, representing 6.0% of shares outstanding.
- The filing is a Schedule 13G, certifying the securities were not acquired with the purpose of changing or influencing control.
- The stake is held across multiple entities: Tang Capital Partners, LP (60,000 shares), Tang Capital Partners International, LP (83,556 shares), Tang Capital Partners III, Inc. (60,002 shares), Tang Capital Partners IV, Inc. (60,002 shares), and Tang Capital Management, LLC (263,560 shares, shared voting/dispositive power).
- The percentage is based on 4,427,676 shares outstanding as of August 11, 2026, per the company's Form 8-K filed August 14, 2026.
- Filing date: October 14, 2026; event date: October 7, 2026.
Financial Impact
6.0% passive stake valued at approximately $1.5 million based on current market price (estimated from 263,560 shares at ~$5.70/share).
Risk Factors
- Passive filing could convert to activist 13D, leading to board changes or strategic review.
- Small-cap biotech with limited liquidity could see volatility on any Tang-related news.
- No specific catalyst identified; filing is purely disclosure of existing position.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001214659-26-012924 |
| Document: 0001214659-26-012924-index-headers.html | 0001214659-26-012924 |
| Document: 0001214659-26-012924-index.html | 0001214659-26-012924 |
| Document: 0001214659-26-012924.txt | 0001214659-26-012924 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | PREM14A | — | awaiting T+20 | — | — |
Oct 14, 2026 12d ago | SC 13G | $1.59 | awaiting T+20 | — | $1.57 (−1.26%) |
Sep 24, 2026 4w ago | Insider Cluster | $1.67 $1.54 | ▼ −7.78% | ▼ −6.31% | $1.57 (−5.99%) |
Sep 24, 2026 4w ago | SC 13D/A | $1.67 $1.54 | ▲ +7.78% | ▲ +6.31% | $1.57 (+5.99%) |
Sep 18, 2026 5w ago | Insider Cluster | $1.78 $1.53 | ▲ +14.04% | ▲ +13.14% | $1.57 (+11.80%) |
Aug 19, 2026 9w ago | DEFA14A | $0.2809 $0.2206 | ▼ −21.46% | ▼ −21.34% | $1.57 (+458.92%) |
Aug 14, 2026 10w ago | 8-K | $0.5015 $0.2487 | ▼ −50.40% | ▼ −48.41% | $1.57 (+213.06%) |
Aug 14, 2026 10w ago | Press Release | $0.5015 $0.2487 | ▲ +50.40% | ▲ +48.41% | $1.57 (−213.06%) |
May 15, 2026 23w ago | 8-K | $0.7780 $0.7184 | ▲ +7.66% | ▲ +9.24% | $1.57 (−101.80%) |
May 12, 2026 23w ago | Press Release | $0.8140 $0.7800 | ▲ +4.18% | ▲ +2.45% | $1.57 (−92.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers